These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10958945)

  • 21. Rapid detection of K-ras mutations in bile by peptide nucleic acid-mediated PCR clamping and melting curve analysis: comparison with restriction fragment length polymorphism analysis.
    Chen CY; Shiesh SC; Wu SJ
    Clin Chem; 2004 Mar; 50(3):481-9. PubMed ID: 14718395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modified mismatch polymerase chain reaction-restriction fragment length polymorphism detected mutations in codon 12 and 13 of exon 2 of K-
    Faleel FD; Zoysa MI; Lokuhetti MD; Gunawardena YI; Chandrasekharan VN; Dassanayake RS
    J Cancer Res Ther; 2016; 12(4):1272-1277. PubMed ID: 28169239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A simple method to reveal possible ras mutations in DNA of urinary sediment cells.
    Cristaudo A; Vivaldi A; Guglielmi G; Sensales G; Ottenga F
    J Environ Pathol Toxicol Oncol; 1997; 16(2-3):201-4. PubMed ID: 9276002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. H-ras oncogene point mutations in arthritic synovium.
    Roivainen A; Jalava J; Pirilä L; Yli-Jama T; Tiusanen H; Toivanen P
    Arthritis Rheum; 1997 Sep; 40(9):1636-43. PubMed ID: 9324018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The balanced induction of K-ras codon 12 and 13 mutations in mucosa differs from their ratio in neoplastic tissues.
    Kraus MC; Seelig MH; Linnemann U; Berger MR
    Int J Oncol; 2006 Oct; 29(4):957-64. PubMed ID: 16964391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A simple method of detecting K-ras point mutations in stool samples for colorectal cancer screening using one-step polymerase chain reaction/restriction fragment length polymorphism analysis.
    Nishikawa T; Maemura K; Hirata I; Matsuse R; Morikawa H; Toshina K; Murano M; Hashimoto K; Nakagawa Y; Saitoh O; Uchida K; Katsu K
    Clin Chim Acta; 2002 Apr; 318(1-2):107-12. PubMed ID: 11880119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
    Conzelmann M; Linnemann U; Berger MR
    Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequent mutations of the p53 gene and infrequent H- and K-ras mutations in urinary bladder carcinomas of NON/Shi mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Yamamoto S; Masui T; Murai T; Mori S; Oohara T; Makino S; Fukushima S; Tatematsu M
    Carcinogenesis; 1995 Oct; 16(10):2363-8. PubMed ID: 7586136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ras gene mutations in human endometrial carcinoma.
    Varras MN; Koffa M; Koumantakis E; Ergazaki M; Protopapa E; Michalas S; Spandidos DA
    Oncology; 1996; 53(6):505-10. PubMed ID: 8960147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutational activation of K-ras in nonneoplastic exocrine pancreatic lesions in relation to cigarette smoking status.
    Berger DH; Chang H; Wood M; Huang L; Heath CW; Lehman T; Ruggeri BA
    Cancer; 1999 Jan; 85(2):326-32. PubMed ID: 10023699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose-dependent ras mutation spectra in N-nitrosodiethylamine induced mouse liver tumors and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced mouse lung tumors.
    Chen B; Liu L; Castonguay A; Maronpot RR; Anderson MW; You M
    Carcinogenesis; 1993 Aug; 14(8):1603-8. PubMed ID: 8353844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection and clinical correlations of ras gene mutations in human ovarian tumors.
    Varras MN; Sourvinos G; Diakomanolis E; Koumantakis E; Flouris GA; Lekka-Katsouli J; Michalas S; Spandidos DA
    Oncology; 1999; 56(2):89-96. PubMed ID: 9949292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A modified mutagenic PCR-RFLP method for K-ras codon 12 and 13 mutations detection in NSCLC patients.
    Hatzaki A; Razi E; Anagnostopoulou K; Iliadis K; Kodaxis A; Papaioannou D; Labropoulos S; Vasilaki M; Kosmidis P; Saetta A; Mihalatos M; Nasioulas G
    Mol Cell Probes; 2001 Oct; 15(5):243-7. PubMed ID: 11735295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. K-ras alterations in Danish ovarian tumour patients. From the Danish "Malova" Ovarian Cancer study.
    Høgdall EV; Høgdall CK; Blaakaer J; Christensen L; Bock JE; Vuust J; Glud E; Kjaer SK;
    Gynecol Oncol; 2003 Apr; 89(1):31-6. PubMed ID: 12694651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. H-RAS mutation is a key molecular feature of pediatric urothelial bladder cancer. A detailed report of three cases.
    Castillo-Martin M; Collazo Lorduy A; Gladoun N; Hyun G; Cordon-Cardo C
    J Pediatr Urol; 2016 Apr; 12(2):91.e1-7. PubMed ID: 26522772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonality and field cancerization in intraductal papillary-mucinous tumors of the pancreas.
    Izawa T; Obara T; Tanno S; Mizukami Y; Yanagawa N; Kohgo Y
    Cancer; 2001 Oct; 92(7):1807-17. PubMed ID: 11745253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [K-ras gene mutation in gallbladder carcinoma].
    Roa JC; Roa I; de Aretxabala X; Melo A; Faría G; Tapia O
    Rev Med Chil; 2004 Aug; 132(8):955-60. PubMed ID: 15478297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma.
    Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P
    Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Screening for K-ras mutations in colorectal and lung cancers by using a novel real-time PCR with ADx-K-ras kit and Sanger DNA sequencing].
    Zhang HP; Fu L; Chen PQ; Ye YB; Ji TH; Zheng LM
    Zhonghua Bing Li Xue Za Zhi; 2010 Nov; 39(11):757-61. PubMed ID: 21215167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening of human bladder tumors and urine sediments for the presence of H-ras mutations.
    Levesque P; Ramchurren N; Saini K; Joyce A; Libertino J; Summerhayes IC
    Int J Cancer; 1993 Nov; 55(5):785-90. PubMed ID: 7902340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.